New York State Common Retirement Fund
NVO

New York State Common Retirement Fund’s Novo Nordisk NVO Stock Holding History

New York State Common Retirement Fund’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Sell
71,765
-27,922
-28% -$1.2M ﹤0.01% 1234
2026
Q1 		$3.66M Buy
99,687
+6,731
+7% +$319K 0.01% 1143
2025
Q4 		$4.73M Sell
92,956
-7,788
-8% -$398K 0.01% 1052
2025
Q3 		$5.59M Sell
100,744
-19,550
-16% -$1.14M 0.01% 1014
2025
Q2 		$8.3M Buy
120,294
+62,355
+108% +$4.24M 0.01% 835
2025
Q1 		$4.02M Sell
57,939
-73,297
-56% -$6.05M 0.01% 1135
2024
Q4 		$11.3M Buy
131,236
+52,568
+67% +$5.68M 0.02% 724
2024
Q3 		$9.37M Sell
78,668
-465
-0.6% -$62K 0.01% 817
2024
Q2 		$11.3M Sell
79,133
-14,123
-15% -$1.87M 0.01% 750
2024
Q1 		$12M Buy
93,256
+34,820
+60% +$4.14M 0.02% 741
2023
Q4 		$6.05M Sell
58,436
-470
-0.8% -$46.5K 0.01% 1047
2023
Q3 		$5.36M Hold
58,906
– – 0.01% 1081
2023
Q2 		$4.77M Buy
58,906
+49,450
+523% +$4.04M 0.01% 1188
2023
Q1 		$752K Hold
9,456
– – ﹤0.01% 1965
2022
Q4 		$640K Hold
9,456
– – ﹤0.01% 2198
2022
Q3 		$471K Hold
9,456
– – ﹤0.01% 2352
2022
Q2 		$527K Sell
9,456
-1,398
-13% -$77.6K ﹤0.01% 2342
2022
Q1 		$603K Sell
10,854
-24,760
-70% -$1.27M ﹤0.01% 2330
2021
Q4 		$1.99M Sell
35,614
-28,840
-45% -$1.56M ﹤0.01% 1772
2021
Q3 		$3.09M Sell
64,454
-17,696
-22% -$855K ﹤0.01% 1520
2021
Q2 		$3.44M Sell
82,150
-20,520
-20% -$795K ﹤0.01% 1529
2021
Q1 		$3.46M Buy
102,670
+96,620
+1,597% +$3.44M ﹤0.01% 1462
2020
Q4 		$211K Sell
6,050
-5,452
-47% -$188K ﹤0.01% 2743
2020
Q3 		$399K Hold
11,502
– – ﹤0.01% 2327
2020
Q2 		$377K Hold
11,502
– – ﹤0.01% 2356
2020
Q1 		$346K Hold
11,502
– – ﹤0.01% 2218
2019
Q4 		$333K Buy
11,502
+2,752
+31% +$76.2K ﹤0.01% 2486
2019
Q3 		$226K Hold
8,750
– – ﹤0.01% 2705
2019
Q2 		$223K Buy
+8,750
New +$216K ﹤0.01% 2754
2016
Q2 		– Sell
-102,342
Closed -$2.77M – 3202
2016
Q1 		$2.77M Sell
102,342
-14,750
-13% -$395K ﹤0.01% 1452
2015
Q4 		$3.4M Sell
117,092
-37,066
-24% -$1.03M 0.01% 1386
2015
Q3 		$4.18M Buy
154,158
+16,716
+12% +$473K 0.01% 1287
2015
Q2 		$3.76M Buy
137,442
+33,854
+33% +$952K 0.01% 1509
2015
Q1 		$2.77M Sell
103,588
-50,768
-33% -$1.17M ﹤0.01% 1520
2014
Q4 		$3.27M Buy
154,356
+17,472
+13% +$390K ﹤0.01% 1409
2014
Q3 		$3.26M Hold
136,884
– – ﹤0.01% 1400
2014
Q2 		$3.16M Buy
136,884
+11,194
+9% +$247K ﹤0.01% 1467
2014
Q1 		$2.87M Hold
125,690
– – ﹤0.01% 1482
2013
Q4 		$2.32M Hold
125,690
– – ﹤0.01% 1579
2013
Q3 		$2.13M Buy
+125,690
New +$2.11M ﹤0.01% 1539

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

New York State Common Retirement Fund's NVO Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Novo Nordisk (NVO) stake by 28% in Q2 2026, selling an estimated $1.2M and leaving 71,765 shares worth $3.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1234.

New York State Common Retirement Fund first reported a position in NVO in Q3 2013 and has held it in 40 quarters since. The position peaked at $12M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • New York State Common Retirement Fund held 71,765 shares of Novo Nordisk worth $3.44M as of Q2 2026.
  • New York State Common Retirement Fund sold 27,922 Novo Nordisk shares in Q2 2026, an estimated $1.2M.
  • Novo Nordisk made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1234 holding.
  • New York State Common Retirement Fund first reported a position in Novo Nordisk in Q3 2013 and has held it in 40 quarters since.
  • New York State Common Retirement Fund's Novo Nordisk position peaked at $12M in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.